Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 3075 of 6351
-
Sound waves aim to quiet shaky hands – at least for a moment
Symptom relief Recruiting nowThis study is being done to test whether low-intensity focused ultrasound (LIFU) (low energy sound waves) cause temporary changes in brain activity and behavior when directed at particular parts of the brain. By targeting LIFU to the parts of the brain thought to be responsible f…
Sponsor: University of California, San Francisco • Aim: Symptom relief
Last updated Jun 27, 2026 09:10 UTC
-
New drug aims to stop Chemo-Induced bleeding risk in stomach and colon cancers
Disease control Recruiting nowThis trial is a single-arm, prospective clinical study aimed at evaluating the efficacy and safety of hetrombopag in preventing chemotherapy-induced thrombocytopenia (CIT) in patients with gastrointestinal tumors. The study plans to enroll 40 patients with gastrointestinal tumors…
Phase 2 • Sponsor: Changhai Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
New drug BTX-A51 tested in rare sarcomas
Disease control OngoingThis study is testing two different doses of BTX-A51 to determine if it is safe and tolerable in participants with liposarcoma with MDM2 amplification, myxoid liposarcoma, and CIC-rearranged sarcoma. The name of the study drug used in this research study is: -BTX-A51 (a type of…
Phase 1 • Sponsor: Michael Wagner, MD • Aim: Disease control
Last updated Jul 03, 2026 00:00 UTC
-
New drug shows promise for nerve disease that affects walking
Symptom relief CompletedThis Phase 2a study aims to evaluate the efficacy, safety and tolerability of NMD670 vs placebo administered twice a day (BID) for 21 days in ambulatory adult patients with Charcot-Marie-Tooth disease type 1 and type 2.
Phase 2 • Sponsor: NMD Pharma A/S • Aim: Symptom relief
Last updated Jun 27, 2026 07:57 UTC
-
Can we predict breast cancer resistance to hormone therapy?
Knowledge-focused Recruiting nowThis is an exploratory phase II interventional study that initiates standard-of-care anti-estrogen treatment preoperatively for 4-12 weeks (+/- 2 weeks).
Phase 2 • Sponsor: Medical College of Wisconsin • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:54 UTC
-
Can a probiotic gel help women clear HPV and early cervical lesions?
Disease control OngoingIn Taiwan, Pap smear screen has been offered every year for women over 30 years old since 1995. The incidence of cervical invasive cancer decreased from 25/100,000 person in 1995 to 7.0/100,1000 person in 2016. In contrast, the incidence of pre-cancerous lesions increased gradual…
Sponsor: National Taiwan University Hospital • Aim: Disease control
Last updated Jun 27, 2026 07:58 UTC
-
New scan could spot sarcomas more clearly, paving way for targeted treatment
Diagnosis Recruiting nowThis trial studies how well 68Ga-DOTATATE digital PET/CT work in diagnosing soft tissue sarcoma. 68Ga-DOTATATE is a radiotracer that may improve image quality of PET imaging. PET is an established imaging technique that utilizes small amounts of radioactivity attached to very min…
Sponsor: Ohio State University Comprehensive Cancer Center • Aim: Diagnosis
Last updated Jun 27, 2026 09:01 UTC
-
Real-Time glucose monitor may help type 2 diabetes patients without insulin
Symptom relief OngoingThis study evaluates the effect of using a real-time continuous glucose monitoring (CGM) system on blood sugar control in people with type 2 diabetes who do not use insulin. Participants will wear a CGM device (CareSens Air) for a total of two weeks. During the first week, the d…
Sponsor: Kangbuk Samsung Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 08:06 UTC
-
New shot could keep pain away longer after surgery
Symptom relief Recruiting nowThis Phase 2 open-label trial investigates the pharmacokinetics (PK), pharmacodynamics, and safety profile of TLC590 across various surgical procedures. Researchers aim to determine the maximum tolerated dose (MTD) of TLC590 via Safety Monitoring Committee (SMC). The study evalu…
Phase 2 • Sponsor: TLC Biopharmaceuticals, Inc. • Aim: Symptom relief
Last updated Jun 27, 2026 08:01 UTC
-
Can pilates or circuit training lower blood pressure in pregnant women?
Disease control CompletedThe purpose of the study is to investigate the effect of Pilates exercises versus circuit exercise training on blood pressure and lipids in gestational hypertensive women.
Sponsor: Cairo University • Aim: Disease control
Last updated Jun 27, 2026 08:05 UTC
-
New study aims to ease emotional burdens of COPD patients
Symptom relief Recruiting nowThe goal of this clinical trial is to understand how a Coping Skills Training program can reduce depression and anxiety in people with chronic obstructive pulmonary disease (COPD), particularly those who face health disparities, including those with low income, different racial b…
Sponsor: University of Pennsylvania • Aim: Symptom relief
Last updated Jun 27, 2026 09:00 UTC
-
VR boosts brain health knowledge in seniors with early memory loss
Knowledge-focused CompletedThe goal of this randomized controlled trial is to evaluate the effectiveness of Virtual Reality (VR)-based cognitive health education for older adults with mild cognitive impairment (MCI) in Taiwan. The study aims to assess whether VR-supported interventions improve cognitive he…
Sponsor: National Taiwan Normal University • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:06 UTC
-
Vibration and cold pack beat pain and fear during chest tube removal
Symptom relief CompletedRemoval of chest tubes after coronary artery bypass graft (CABG) surgery can cause severe pain and anxiety, which may negatively affect the recovery process. Integrating non-pharmacological methods into nursing care can help manage pain and anxiety safely and effectively. This s…
Sponsor: Istanbul University - Cerrahpasa • Aim: Symptom relief
Last updated Jun 27, 2026 11:01 UTC
-
Can leg presses keep aging brains and bodies stronger?
Disease control CompletedThis study is an exercise intervention assessing the efficacy of a velocity-based resistance training (VBRT) in institutionalized older adults. The aim of this study is to assess the effects of one year of velocity-based resistance training on skeletal muscle mass, muscle functi…
Sponsor: University of Castilla-La Mancha • Aim: Disease control
Last updated Jun 27, 2026 12:26 UTC
-
Botox shots aim to ease light pain in brain injury patients
Symptom relief Recruiting nowThe purpose of this research is to understand and treat Traumatic Brain Injury (TBI) associated photophobia (light sensitivity) and its impact on visual function.
Phase 2 • Sponsor: University of Miami • Aim: Symptom relief
Last updated Aug 16, 2026 00:00 UTC
-
Learning to save limbs: education program aims to cut hospital stays
Symptom relief CompletedCritical limb ischemia (CLI) is a severe condition where poor blood flow to the legs causes pain, non-healing wounds, and may require amputation. It affects 10% of people over 40, rising to 20% in those over 70. Within the first year after diagnosis, 30% of patients need amputati…
Sponsor: Tulip Medicine • Aim: Symptom relief
Last updated Jun 27, 2026 11:00 UTC
-
Texts and family classes aim to tame childhood obesity in Low-Income homes
Disease control Recruiting nowThis hybrid type 3 effectiveness-implementation sequential multiple assignment randomized trial will assess the impact of integrating population health management (PHM) strategies-text messaging and enrollment in Building Healthy Families (BHF)-for lower-income families with a ch…
Sponsor: Paul Estabrooks • Aim: Disease control
Last updated Jun 27, 2026 11:02 UTC
-
Could a heart drug help kidney patients? new trial tests finerenone for membranous nephropathy
Disease control Recruiting nowThis is a prospective, randomized, multicenter, controlled trial. One hundred sixteen patients with primary membranous nephropathy (PMN) will be randomly divided into the intervention and control groups. The intervention group will be administered maximum tolerable dose of ACEI/A…
Phase 4 • Sponsor: First Affiliated Hospital, Sun Yat-Sen University • Aim: Disease control
Last updated Jun 27, 2026 12:06 UTC
-
Strawberry substance tested to boost mobility in artery disease patients
Symptom relief Recruiting nowThe investigators propose a pilot randomized trial to gather preliminary data to test the hypothesis that Fisetin will reduce abundance of senescent cells in blood, skeletal muscle, and both subcutaneous and inter muscular adipose tissue and improve 6-minute walk distance in 34 p…
Phase 2 • Sponsor: Northwestern University • Aim: Symptom relief
Last updated Jun 27, 2026 12:08 UTC
-
Virtual heart program aims to keep patients out of hospital
Disease control CompletedThe purpose of this study is to evaluate how safe and effective a remote, virtual, cardiology program is that provides heart failure education to patients, monitors for worsening heart failure, and quickly adjusts heart failure medications, compared to usual care medication use a…
Sponsor: Duke University • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC